Research links variations in the gene GRIN2A to a higher risk of developing schizophrenia and other forms of mental illness.

A major scientific review reveals a deep knowledge gap in how cognition is affected when schizophrenia and personality disorders occur together.

As treatment for schizophrenia changes, LAIs are becoming increasingly important as maintenance therapy. Teva's pursuit of an ...

Schizophrenia has long been framed as a disorder of broken thoughts and fractured perception, but a new line of research ...

Cobenfy’s efficacy at treating the symptoms of patients with psychosis may vary between subgroups, according to a post-hoc ...

Dual art therapy, combining music and painting, significantly improved symptoms, cognitive function, and quality of life in ...

A new study by a research team at Université de Montréal highlights a critical lack of knowledge about the cognitive profiles ...

Neurocrine Biosciences ($NBIX) announced an update on their ongoing clinical study. Neurocrine Biosciences has initiated a Phase 3 study titled ‘A ...

New brain imaging research shows that structural damage in schizophrenia spectrum disorders may begin in specific “epicenter” regions before spreading across connected brain networks.

Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with ...

Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...